A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : SSRIs

Search Conditions:
Search Keyword : SSRIs
Search Method : Exact match.
Research Area:

Abbreviation: SSRIs
Appearance Frequency: 4779 time(s)
Long forms: 19

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
selective serotonin reuptake inhibitors
(4548 times)
(1056 times)
TCAs (451 times)
SNRIs (365 times)
MDD (255 times)
1992 Comparative efficacy of antidepressants.
serotonin selective reuptake inhibitors
(147 times)
(71 times)
TCAs (20 times)
MAOIs (12 times)
OCD (10 times)
1993 Acute therapy of depression.
selective serotonin reuptake inhibitor antidepressants
(25 times)
(7 times)
TCAs (3 times)
HPA (2 times)
MI (2 times)
1997 A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies.
selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors
(24 times)
Drug Therapy
(19 times)
TCAs (6 times)
MAOIs (3 times)
NaSSA (2 times)
1994 Pharmacokinetic optimisation of therapy with newer antidepressants.
selective serotonin inhibitors
(12 times)
(3 times)
SNRIs (2 times)
ADS (1 time)
aOR (1 time)
2000 Citalopram and breast-feeding: serum concentration and side effects in the infant.
serotonergic antidepressants
(6 times)
(3 times)
APs (1 time)
CPA (1 time)
EO (1 time)
1996 Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations.
Several selective 5-HT reuptake inhibitors
(4 times)
(2 times)
TRD (1 time)
1996 Venlafaxine oxidation in vitro is catalysed by CYP2D6.
selective SRIs
(2 times)
(1 time)
SRIs (2 times)
CBT (1 time)
dPAG (1 time)
2007 Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze.
second-generation antidepressants
(1 time)
(1 time)
MAOIs (1 time)
SNRIs (1 time)
TCAs (1 time)
2009 [Clinically relevant drug interactions with new generation antidepressants and antipsychotics].
10  second-generation antidepressants, in particular of selective 5-HT reuptake inhibitors
(1 time)
Drug Therapy
(1 time)
MD (1 time)
SERT (1 time)
2013 The role of platelet/lymphocyte serotonin transporter in depression and beyond.
11  selective reuptake inhibitors of serotonin
(1 time)
(1 time)
--- 2008 Don't be afraid to treat depression in patients with epilepsy!
12  Selective Serotonin presynaptic Reuptake Inhibition
(1 time)
(1 time)
RIMAs (1 time)
1997 [Indications for new antidepressants with reference to ICD-10: a waggish question or the future of psychiatry?].
13  serotonin reuptake sites inhibitors
(1 time)
(1 time)
BP (1 time)
OCD (1 time)
2006 Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naive patients.
14  sexual disturbances
(1 time)
Mental Disorders
(1 time)
IEED (1 time)
TCAs (1 time)
2007 Involuntary emotional expression disorder: treating the untreated.
15  should include recommendations for antipsychotic therapy, the use of antidepressants
(1 time)
(1 time)
CBD (1 time)
FTD (1 time)
2022 [Frontotemporal dementia with cortico-basal syndrome].
16  SNRIs and selective inhibitors of 5-HT
(1 time)
Nervous System
(1 time)
MDD (1 time)
TM6 (1 time)
2018 What Contributes to Serotonin-Norepinephrine Reuptake Inhibitors' Dual-Targeting Mechanism? The Key Role of Transmembrane Domain 6 in Human Serotonin and Norepinephrine Transporters Revealed by Molecular Dynamics Simulation.
17  Some of these have been linked to decreased BMD
(1 time)
(1 time)
BMD (1 time)
2012 Antidepressant medications and osteoporosis.
18  subacute, administration of selective 5-HT reuptake inhibitors
(1 time)
(1 time)
LC (1 time)
NE (1 time)
2001 Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.
19  subclasses--Selective Serotonin Reuptake Inhibitors
(1 time)
(1 time)
CI (1 time)
2008 Utilization, price, and spending trends for antidepressants in the US Medicaid Program.